8-K
filed December 20, 2023, 6:59 PM ET
ticker CELZ
CIK 0001187953
other material
confidence high
sentiment neutral
materiality 0.15
Shareholders elect all five director nominees and approve say-on-pay at annual meeting
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- Quorum of 55.9% (776,982 shares) present at December 20, 2023 annual meeting.
- All five director nominees elected with 234,462 to 237,729 votes in favor; no dissent above 26,758.
- Say-on-pay approved: 169,498 for, 90,645 against, 1,077 abstain, 515,762 broker non-votes.
- Ratification of auditor Haynie & Company approved: 751,848 for, 23,485 against, 1,649 abstain.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Election of five director nominees to the Board at the 2023-12-20 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-12-20
Exact text from the filing
Timothy Warbington 237,163 24,057 Donald Dickerson 237,192 24,028 Michael H. Finger 234,462 26,758 Susan Snow 237,729 23,491 Bruce S. Urdang, Esq. 235,547 25,673
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Approval of the compensation of the Company's named executive officers at the 2023-12-20 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-12-20
Exact text from the filing
For Against Abstain Broker Non-Votes 169,498 90,645 1,077 515,762
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Ratification of the appointment of Haynie & Company to serve as the Company's independent registered public accountants at the 2023-12-20 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-20
Exact text from the filing
For Against Abstain Broker Non-Votes 751,848 23,485 1,649 N/A
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.